# UnitedHealth Group / EMIS merger inquiry
The CMA is investigating the anticipated acquisition by UnitedHealth Group Incorporated, via Bordeaux UK Holdings II Limited, of EMIS Group Plc.
From:[Competition and Markets Authority](/government/organisations/competition-and-markets-authority)Published20 January 2023Last updated
29 September 2023
— [See all updates](#full-publication-update-history)
Case type:[Mergers](/cma-cases?case_type%5B%5D=mergers)Case state:[Closed](/cma-cases?case_state%5B%5D=closed)Market sector:[Healthcare and medical equipment](/cma-cases?market_sector%5B%5D=healthcare-and-medical-equipment)Outcome:[Mergers - phase 2 clearance](/cma-cases?outcome_type%5B%5D=mergers-phase-2-clearance)Opened:
20 January 2023
Closed:
29 September 2023
## Phase 2
### Administrative timetable
Date of referral: 31 March 2023
Statutory deadline: 5 October 2023
- [Administrative timetable (PDF, 91.9 KB)](https://assets.publishing.service.gov.uk/media/6463cbf70b72d300133445c3/Administrative_timetable.pdf) (17.5.23)
### Contact
[UnitedHealth.EMIS@cma.gov.uk](mailto:UnitedHealth.EMIS@cma.gov.uk)
### Final report
29 September 2023: The CMA has published its final report.
- [Final report (PDF, 1476KB)](https://assets.publishing.service.gov.uk/media/6516ca296dfda6000d8e38dc/Final_report___.pdf) (29.9.23)
- [Appendices and glossary (PDF, 302KB)](https://assets.publishing.service.gov.uk/media/6516c5736dfda6000d8e38d6/Appendices_and_glossary.pdf) (29.9.23)
- [Summary of final report (PDF, 140KB)](https://assets.publishing.service.gov.uk/media/6515a5407c2c4a001395e1f2/Summary.pdf) (29.9.23)
- [Press release: CMA clears NHS healthcare tech deal](https://www.gov.uk/government/news/cma-clears-nhs-healthcare-tech-deal) (29.9.23)
### Responses to provisional findings
- [UH/EMIS (PDF, 139KB)](https://assets.publishing.service.gov.uk/media/6500361b572780000d251981/UHEMIS_.pdf) (13.9.23)
- [Market Participant A (PDF, 65KB)](https://assets.publishing.service.gov.uk/media/650035dc572780000d25197f/Market_Participant_A_.pdf) (13.9.23)
- [FDB (PDF, 219KB)](https://assets.publishing.service.gov.uk/media/650035b15727800014251987/FDB_.pdf) (13.9.23)
- [TPP (PDF, 106KB)](https://assets.publishing.service.gov.uk/media/650035fc572780000d251980/TPP_.pdf) (13.9.23)
### Provisional findings
11 August 2023: The CMA has provisionally cleared the anticipated acquisition by UnitedHealth Group Incorporated of EMIS Group Plc.
The deadline for submitting responses to the provisional findings is 5pm on Friday 1 September 2023.
- [Provisional findings (PDF, 1,112KB)](https://assets.publishing.service.gov.uk/media/64fb1e411886eb000d977026/PFs__FOR_PUBLICATION_updated_.pdf) (11.8.23)
- [Appendices and glossary (PDF, 259KB)](https://assets.publishing.service.gov.uk/media/64d613999607100013b27e28/PFs_Appendices__FOR_PUBLICATION__A.pdf) (11.8.23)
- [Summary of provisional findings (PDF, 139KB)](https://assets.publishing.service.gov.uk/media/64d4d7c35cac650014c2dd6a/Summary_of_provisional_findings.pdf) (11.8.23)
- [Notice of provisional findings (PDF, 122KB)](https://assets.publishing.service.gov.uk/media/64d4d7dd9865ab0013c8fb8b/Optum_EMIS_-Notice_of_PFs.pdf) (11.8.23)
- Press release: [CMA provisionally clears NHS healthcare tech deal](https://www.gov.uk/government/news/cma-provisionally-clears-nhs-healthcare-tech-deal) (11.8.23)
### Response to the issues statement
- [UnitedHealth Group Incorporated and EMIS Group PLC (PDF, 636KB)](https://assets.publishing.service.gov.uk/media/649303df5f7bb7000c7faefa/Response_to_Issues_Statement_-_Anticipated_Acquisition_UnitedHealth_Group_Inco_.pdf) (22.6.23)
- [Investment firm (PDF, 268KB)](https://assets.publishing.service.gov.uk/media/64930405103ca6001303a388/EMIS_comment_letter_.pdf) (22.6.23)
### Issues statement
17 May 2023: The issues statement sets out the scope of the inquiry. It outlines initial theories on what might be adversely affecting competition, but it does not set out findings or conclusions.
- [Issues statement (PDF, 215 KB)](https://assets.publishing.service.gov.uk/media/64641436d3231e001332daa3/Issues_statement.pdf) (17.5.23)
### Notice of extension
- [Notice of extension of inquiry period (PDF, 96.3KB)](https://assets.publishing.service.gov.uk/media/6448fee8f126830011ca684f/Notice_of_extension_section_39_8A_UnitedHealth_EMIS.pdf) (27.4.23)
### Inquiry group appointed
31 March 2023: The CMA has appointed the inquiry group.
[Kirstin Baker](https://www.gov.uk/government/publications/cma-panel-member-biographies-and-disclosures-of-interest/inquiry-chairs-biographies#kirstin-baker) (Chair), [Ulrike Hotopp](https://www.gov.uk/government/publications/cma-panel-member-biographies-and-disclosures-of-interest/panel-members-biographies#ulrike-hotopp), [Frances McLeman](https://www.gov.uk/government/publications/cma-panel-member-biographies-and-disclosures-of-interest/panel-members-biographies#frances-mcleman) and [Sir Kenneth Parker](https://www.gov.uk/government/publications/cma-panel-member-biographies-and-disclosures-of-interest/panel-members-biographies#sir-kenneth-parker).
### Terms of reference
31 March 2023: The CMA has referred the anticipated acquisition by UnitedHealth Group Incorporated of EMIS Group Plc for an in-depth investigation.
- [Terms of reference (PDF, 99.8 KB)](https://assets.publishing.service.gov.uk/media/6426e8abfbe620000c17da81/Terms_of_reference_-OPTUM-EMIS__FOR_PUBLICATION_.pdf) (31.3.23)
## Phase 1
### Statutory timetable
| Date | Action |
| --- | --- |
| 17 March 2023 | Decision announced |
| 20 January 2023 | Launch of merger inquiry |
| 20 January 2023 to 3 February 2023 | Invitation to comment |
### Reference decision
31 March 2023: The CMA has referred the anticipated acquisition by UnitedHealth Group Incorporated of EMIS Group Plc for an in-depth investigation, on the basis that, on the information currently available to it, it is or may be the case that this merger has resulted or may be expected to result in a substantial lessening of competition within a market or markets in the United Kingdom.
- [Decision to refer (PDF, 161 KB)](https://assets.publishing.service.gov.uk/media/6463d165e14070000cb6e051/Decision_to_refer.pdf) (17.5.23)
### Reference unless undertakings accepted
17 March 2023: The CMA has decided, on the information currently available to it, that it is or may be the case that this merger may be expected to result in a substantial lessening of competition within a market or markets in the United Kingdom. This merger will be referred for a phase 2 investigation unless the parties offer acceptable undertakings to address these competition concerns.
- [Full text decision (PDF, 703 KB)](https://assets.publishing.service.gov.uk/media/64640f6a0b72d300133445c6/SLC_full_text_decision.pdf) (17.5.23)
- [Summary of Phase 1 decision (PDF. 158KB)](https://assets.publishing.service.gov.uk/media/6414236bd3bf7f79dd8acc74/Optum-EMIS.a_-_Summary_of_P1_Decision.pdf) (17.3.23)
- Press release: [Healthcare deal could lead to higher costs for NHS](https://www.gov.uk/government/news/healthcare-deal-could-lead-to-higher-costs-for-nhs) (17.3.23)
### Launch of merger inquiry
20 January 2023: The CMA announced the launch of its merger inquiry by notice to the parties.
- [Commencement notice (PDF, 102KB)](https://assets.publishing.service.gov.uk/media/63c965afe90e0707165d224e/Optum-EMIS___Notice_commencement_initial_period__FOR_PUBLICATION_.pdf) (20.1.23)
### Invitation to comment: closed
20 January 2023: The Competition and Markets Authority (CMA) is considering whether it is or may be the case that this transaction, if carried into effect, will result in the creation of a relevant merger situation under the merger provisions of the Enterprise Act 2022 and, if so, whether the creation of that situation may be expected to result in a substantial lessening of competition within any market or markets in the United Kingdom for goods or services.
To assist it with this assessment, the CMA invites comments on the transaction from any interested party.
These comments should be provided by the deadline set out above.
## Contact
Please send written representations about any competition or public interest issues to:
[general.enquiries@cma.gov.uk](mailto:general.enquiries@cma.gov.uk)
## Updates to this page
Published 20 January 2023
Last updated 29 September 2023
[+ show all updates](#full-history)
01. 29 September 2023
Final report, appendices and glossary published
02. 29 September 2023
Summary of final report published
03. 13 September 2023
Responses to the provisional findings published.
04. 11 August 2023
Provisional findings and Appendices and glossary published
05. 11 August 2023
Provisional findings published
06. 17 May 2023
Phase 1 full text decision, Decision to refer, Issues statement and Administrative timetable published.
07. 27 April 2023
Notice of extension published.
08. 31 March 2023
Inquiry group appointed and terms of reference published.
09. 31 March 2023
Reference decision announced.
10. 17 March 2023
Summary of the Phase 1 decision published
11. 20 January 2023
First published.
[Contents](#contents)